Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment / Maurizio Fava en The Journal of Clinical Psychiatry, Año 2011 - Vol.72 - No. 7 (Julio)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 7 (Julio) . - pp. 914-928 Título : Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment : a randomized controlled trial Tipo de documento: texto impreso Autores: Maurizio Fava, Autor ; Gregory M. Asnis, Autor ; Ram K. Shrivastava, Autor Fecha de publicación: 2022 Artículo en la página: pp. 914-928 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Citalopram, Trastorno depresivo mayor, Farmacoterapia, Hipnóticos y sedantes, Piridinas, Trastornos de iniciación y mantenimiento del sueño, Vigilia. Resumen: This investigation was performed to assess the efficacy and safety of zolpidem extended-release in patients with insomnia associated with major depressive disorder (MDD). Link: ./index.php?lvl=notice_display&id=28023 [artículo] Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment : a randomized controlled trial [texto impreso] / Maurizio Fava, Autor ; Gregory M. Asnis, Autor ; Ram K. Shrivastava, Autor . - 2022 . - pp. 914-928. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2011 - Vol.72 - No. 7 (Julio) . - pp. 914-928 Palabras clave: Antidepresivos, Citalopram, Trastorno depresivo mayor, Farmacoterapia, Hipnóticos y sedantes, Piridinas, Trastornos de iniciación y mantenimiento del sueño, Vigilia. Resumen: This investigation was performed to assess the efficacy and safety of zolpidem extended-release in patients with insomnia associated with major depressive disorder (MDD). Link: ./index.php?lvl=notice_display&id=28023

Zolpidem extended release improves sleep and next day symptoms in comorbid insomnia and generalized anxiety disorder / Maurizio Fava en Journal of Clinical Psychopharmacology, Año 2009 - Vol. 29 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 3 (Junio) . - pp. 222-230 Título : Zolpidem extended release improves sleep and next day symptoms in comorbid insomnia and generalized anxiety disorder Tipo de documento: texto impreso Autores: Maurizio Fava, Autor ; Gregory M. Asnis, Autor ; Ram K. Shrivastava, Autor Fecha de publicación: 2022 Artículo en la página: pp. 222-230 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Zolpidem de liberación prolongada, Insomnio, Trastorno de ansiedad generalizada, Ensayo controlado aleatorio, Farmacoterapia concomitante, Escitalopram Resumen: A multicenter, double-blind, parallel-group study was designed to assess the efficacy and safety of zolpidem extended-release coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Patients (N = 383) received open-label escitalopram 10 mg/d and were randomized to either adjunct zolpidem extended-release 12.5 mg or placebo. Link: ./index.php?lvl=notice_display&id=29502 [artículo] Zolpidem extended release improves sleep and next day symptoms in comorbid insomnia and generalized anxiety disorder [texto impreso] / Maurizio Fava, Autor ; Gregory M. Asnis, Autor ; Ram K. Shrivastava, Autor . - 2022 . - pp. 222-230. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2009 - Vol. 29 - No. 3 (Junio) . - pp. 222-230 Palabras clave: Zolpidem de liberación prolongada, Insomnio, Trastorno de ansiedad generalizada, Ensayo controlado aleatorio, Farmacoterapia concomitante, Escitalopram Resumen: A multicenter, double-blind, parallel-group study was designed to assess the efficacy and safety of zolpidem extended-release coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Patients (N = 383) received open-label escitalopram 10 mg/d and were randomized to either adjunct zolpidem extended-release 12.5 mg or placebo. Link: ./index.php?lvl=notice_display&id=29502

---

1 (1 - 2 / 2)